Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted ...

Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on March 1, 2025 the Company granted ...

North Mill Equipment Finance is set to acquire Pawnee Leasing Corporation and its affiliated company, Tandem Finance, in a ...

Their permissioned multi-chain model is interesting - it addresses regulatory concerns while maintaining the core benefits of ...

Read on to learn what is a safe harbor 401k and why it might be a good fit for both small businesses and people who love the ...

“We are pleased that Algernon NeuroScience has selected Netcapital Securities as its broker-dealer to provide critical compliance and operational support for this offering,” said Martin Kay, CEO at ...

In a significant ruling on February 5, 2025, the U.S. Court of Appeals for the Second Circuit addressed the enforceability of an arbitration ...

CVR-no. 44 79 14 47, ("Svitzer Group" or the "Company") has today decided to implement a new share-based incentive plan for 2025 ...

Cronos (CRO) price extends its gains by 7%, trading around $0.086 on Thursday after rallying nearly 8% the previous day.

Under-the-radar move: Signing 41-year-old Charlie Morton, who logged a 4.19 ERA over 30 starts last season, away from the ...

At the outset of the offseason, the Seattle Mariners declined a $12 million team option on infielder Jorge Polanco. However, the M's were able to bring him back ...

SAINT JOHN – A new multipurpose facility adjacent to the Irving Field House on the east side is a little closer to reality ...